Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania

Journal of Medical Virology

Volumn 84, Issue 8, 2012, Pages 1186-1198

  Mansour, Wael ^a,b   Malick, F Zahra Fall ^c   Sidiya, Ahmad ^d   Ishagh, Elkhalil ^e   Chekaraou, Mariama Abdou ^f   Veillon, Pascal ^a,b   Ducancelle, Alexandra ^a,b   Brichler, Ségolène ^f   Le Gal, Frédéric ^f   Lo, Baidy ^c   Gordien, Emmanuel ^f   Lunel Fabiani, Françoise ^a,b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c Public Health National Institute (INRSP)   (Mauritania)

^d Arafat Public Health Center   (Mauritania)

^e National Hospital   (Mauritania)

^f UNIVERSITÉ PARIS 13   (France)

Author keywords

Epidemiology; Genotypes; Hepatitis B virus; Hepatitis Delta virus; Mauritania

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; DELTA AGENT HEPATITIS; ETHNICITY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; MAJOR CLINICAL STUDY; MAURITANIA; MOLECULAR EPIDEMIOLOGY; NUCLEOTIDE SEQUENCE; OCCUPATION; PREGNANT WOMAN; PREVALENCE; RISK FACTOR; VIRUS DETECTION; VIRUS LOAD; VIRUS STRAIN;

ADOLESCENT; ADULT; AGED; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; MALE; MAURITANIA; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84862674762     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23336     Document Type: Article

References (47)

1. Abdou Chekaraou M, Brichler S, Mansour W, Le Gal F, Garba A, Deny P, Gordien E. 2010. A novel hepatitis B virus (HBV) subgenotype D (D8) strain, resulting from recombination between genotypes D and E, is circulating in Niger along with HBV/E strains. J Gen Virol 91: 1609-1620.
2. Abe H, Ochi H, Maekawa T, Hayes CN, Tsuge M, Miki D, Mitsui F, Hiraga N, Imamura M, Takahashi S, Ohishi W, Arihiro K, Kubo M, Nakamura Y, Chayama K. 2010. Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients. J Hepatol 53: 439-443.
3. Abou-Jaoude G, Sureau C. 2007. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange. J Virol 81: 13057-13066.
4. Acquaye JK, Mingle JA. 1994. Hepatitis B viral markers in Ghanaian pregnant women. West Afr J Med 13: 134-137.
5. Adoga MP, Gyar SD, Pechulano S, Bashayi OD, Emiasegen SE, Zungwe T, Iperepolu OH, Agupugo C, Agwale SM. 2010. Hepatitis B virus infections in apparently healthy urban Nigerians: data from pre-vaccination tests. J Infect Dev Ctries 4: 397-400.
6. Bwogi J, Braka F, Makumbi I, Mishra V, Bakamutumaho B, Nanyunja M, Opio A, Downing R, Biryahwaho B, Lewis RF. 2009. Hepatitis B infection is highly endemic in Uganda: Findings from a national serosurvey. Afr Health Sci 9: 98-108.
7. Candotti D, Danso K, Allain JP. 2007. Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa. J Gen Virol 88: 2686-2695.
8. Deiman B, Jay C, Zintilini C, Vermeer S, van Strijp D, Venema F, van de Wiel P. 2008. Efficient amplification with NASBA of hepatitis B virus, herpes simplex virus and methicillin resistant Staphylococcus aureus DNA. J Virol Methods 151: 283-293.
9. Djebbi A, Rebai WK, Bahri O, Hogga N, Sadraoui A, Triki H. 2009. Serological markers, viral RNA and genotype of hepatitis delta virus in HBs antigen positive Tunisian patients. Pathol Biol (Paris) 57: 518-523.
10. Drucker E, Alcabes PG, Marx PA. 2001. The injection century: massive unsterile injections and the emergence of human pathogens. Lancet 358: 1989-1992.
11. Dumpis U, Holmes EC, Mendy M, Hill A, Thursz M, Hall A, Whittle H, Karayiannis P. 2001. Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis. J Hepatol 35: 99-104.
12. Farci P, Chessa L, Balestrieri C, Serra G, Lai ME. 2007. Treatment of chronic hepatitis D. J Viral Hepat 14: 58-63.
13. Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, Schalm SW. 2000. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut 46: 420-426.
14. Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, Lobello S, Sagnelli E, Brunetto MR, Rizzetto M. 2000. Chronic hepatitis D: A vanishing Disease? An Italian multicenter study. Hepatology 32: 824-827.
15. Gall D. 1954. The chemoprophylaxis of sleeping sickness with the diamidines. Ann Trop Med Parasitol 48: 242-258.
16. Guo X, Zhang Y, Li J, Ma J, Wei Z, Tan W, O'Brien SJ. 2011. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology 53: 422-428.
17. Herbert EW. 1975. Smallpox inoculation in Africa. J Afr Hist 16: 539-559.
18. Huy TT, Ishikawa K, Ampofo W, Izumi T, Nakajima A, Ansah J, Tetteh JO, Nii-Trebi N, Aidoo S, Ofori-Adjei D, Sata T, Ushijima H, Abe K. 2006. Characteristics of hepatitis B virus in Ghana: Full length genome sequences indicate the endemicity of genotype E in West Africa. J Med Virol 78: 178-184.
19. Ivaniushina V, Radjef N, Alexeeva M, Gault E, Semenov S, Salhi M, Kiselev O, Deny P. 2001. Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, Russia. J Gen Virol 82: 2709-2718.
20. Kew MC. 1996. Progress towards the comprehensive control of hepatitis B in Africa: A view from South Africa. Gut 38: S31-S36.
21. Kramvis A, Kew MC. 2007. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res 37: S9-S19.
22. Kramvis A, Kew M, Francois G. 2005. Hepatitis B virus genotypes. Vaccine 23: 2409-2423.
23. Le Gal F, Gault E, Ripault MP, Serpaggi J, Trinchet JC, Gordien E, Deny P. 2006. Eighth major clade for hepatitis delta virus. Emerg Infect Dis 12: 1447-1450.
24. Lindh M, Gonzalez JE, Norkrans G, Horal P. 1998. Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon. J Virol Methods 72: 163-174.
25. Madzime S, Adem M, Mahomed K, Woelk GB, Mudzamiri S, Williams MA. 1999. Hepatitis B virus infection among pregnant women delivering at Harare Maternity Hospital, Harare Zimbabwe, 1996 to 1997. Cent Afr J Med 45: 195-198.
26. Makuwa M, Souquiere S, Telfer P, Apetrei C, Vray M, Bedjabaga I, Mouinga-Ondeme A, Onanga R, Marx PA, Kazanji M, Roques P, Simon F. 2006. Identification of hepatitis B virus subgenotype A3 in rural Gabon. J Med Virol 78: 1175-1184.
27. Makuwa M, Caron M, Souquiere S, Malonga-Mouelet G, Mahe A, Kazanji M. 2008. Prevalence and genetic diversity of hepatitis B and delta viruses in pregnant women in Gabon: Molecular evidence that hepatitis delta virus clade 8 originates from and is endemic in central Africa. J Clin Microbiol 46: 754-756.
28. Martinson FE, Weigle KA, Royce RA, Weber DJ, Suchindran CM, Lemon SM. 1998. Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana. Am J Epidemiol 147: 478-487.
29. Meldal BH, Moula NM, Barnes IH, Boukef K, Allain JP. 2009. A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol 90: 1622-1628.
30. Mulders MN, Venard V, Njayou M, Edorh AP, Bola Oyefolu AO, Kehinde MO, Muyembe Tamfum JJ, Nebie YK, Maiga I, Ammerlaan W, Fack F, Omilabu SA, Le Faou A, Muller CP. 2004. Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa. J Infect Dis 190: 400-408.
31. Ndumbe PM, Atchou G, Biwole M, Lobe V, Ayuk-Takem J. 1993. Infections among pygmies in the Eastern Province of Cameroon. Med Microbiol Immunol 182: 281-284.
32. Niro GA, Casey JL, Gravinese E, Garrubba M, Conoscitore P, Sagnelli E, Durazzo M, Caporaso N, Perri F, Leandro G, Facciorusso D, Rizzetto M, Andriulli A. 1999. Intrafamilial transmission of hepatitis delta virus: molecular evidence. J Hepatol 30: 564-569.
33. Ojo OS, Thursz M, Thomas HC, Ndububa DA, Adeodu OO, Rotimi O, Lawal AA, Durosinmi MA, Akonai AK, Fatusi AO, et al. 1995. Hepatitis B virus markers, hepatitis D virus antigen and hepatitis C virus antibodies in Nigerian patients with chronic liver disease. East Afr Med J 72: 719-721.
34. Okpalugo CE, Oguntibeju OO. 2008. Prevalence of human immunodeficiency virus and hepatitis B virus in preoperative patients: Potential risk of transmission to health professionals. Pak J Biol Sci 11: 298-301.
35. Oshitani H, Kasolo F, Tembo C, Mpabalwani M, Mizuta K, Luo N, Suzuki H, Numazaki Y. 1995. Hepatitis B virus infection among pregnant women in Zambia. East Afr Med J 72: 813-815.
36. Pellizzer G, Ble C, Zamperetti N, Stroffolini T, Upunda G, Rapicetta M, Chionne P, Villano U, Fabris P, de Lalla F. 1994. Serological survey of hepatitis B infection in Tanzania. Public Health 108: 427-431.
37. Radjef N, Gordien E, Ivaniushina V, Gault E, Anais P, Drugan T, Trinchet JC, Roulot D, Tamby M, Milinkovitch MC, Deny P. 2004. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol 78: 2537-2544.
38. Rizzetto M. 2009. Hepatitis D: Thirty years after. J Hepatol 50: 1043-1050.
39. Rizzetto M, Hoyer B, Canese MG, Shih JW, Purcell RH, Gerin JL. 1980. Delta agent: Association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci U S A 77: 6124-6128.
40. Roingeard P, Sankale JL, Dubois F, Diouf A, Bacha A, Mboup S, Goudeau A. 1992. Infection due to hepatitis delta virus in Africa: Report from Senegal and review. Clin Infect Dis 14: 510-514.
41. Romeo R, Del Ninno E, Rumi M, Russo A, Sangiovanni A, de Franchis R, Ronchi G, Colombo M. 2009. A 28-year study of the course of hepatitis Delta infection: A risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology 136: 1629-1638.
42. Rui WZ, Lo Baidy B, N'Diaye M. 1998. Hepatitis B virus infection in the school milieu of Kiffa and Selibaby, Mauritania. Bull Soc Pathol Exot 91: 247-248.
43. Sidibe S, Sacko BY, Traore I. 2001. Prevalence of serologic markers of the hepatitis B virus in pregnant women of Bamako, Mali. Bull Soc Pathol Exot 94: 339-341.
44. Tognarelli B, Coste J, Pradines C, Larrey D, Michel H. 1994. Prevalence of hepatitis delta virus among asymptomatic HBs+ antigen blood donors and in HBs+ antigen hepatopathies in Mauritania. Gastroenterol Clin Biol 18: 176.
45. Triki H, Said N, Ben Salah A, Arrouji A, Ben Ahmed F, Bouguerra A, Hmida S, Dhahri R, Dellagi K. 1997. Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans R Soc Trop Med Hyg 91: 11-114.
46. Wedemeyer H, Heidrich B, Manns MP. 2007. Hepatitis D virus infection-not a vanishing disease in Europe! Hepatology 45: 1331-1332; author reply 1332-1333.
47. WHO. 2004. Hepatitis B vaccines. Wkly Epidemiol Rec 79: 255-263.